BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 106 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,020,000 | +0.9% | 125,307 | 0.0% | 0.01% | -9.1% |
| Q4 2018 | $1,011,000 | +1613.6% | 125,307 | +942.6% | 0.01% | +1000.0% |
| Q4 2017 | $59,000 | -6.3% | 12,019 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $63,000 | -6.0% | 12,019 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $67,000 | -33.7% | 12,019 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $101,000 | +46.4% | 12,019 | +10.9% | 0.00% | 0.0% |
| Q4 2016 | $69,000 | +122.6% | 10,838 | +52.2% | 0.00% | 0.0% |
| Q3 2016 | $31,000 | – | 7,121 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |